The market's overconfidence in the business a year ago is evident as the EPS reduction isn't as severe as the share price drop. The company's five-year performance led to a 5% annual loss for shareholders. Investors should monitor the fundamentals for potential opportunities.
The company's investments are not yielding high returns despite increased capital employed. The rise in current liabilities and the stock's 17% loss in the last five years indicate market skepticism about future improvements.
Despite China Resources Medical Holdings' declining earnings, the high P/E ratio points to investors' optimism for a bounce-back, backed by strong growth expectations. Hard to see share price falling soon.
$華潤醫療(01515.HK)$ China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and exter...
$國藥控股(01099.HK)$ Sinopharm is principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is en...
華潤醫療股票討論區
China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and exter...
Sinopharm is principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is en...
DBS: China Healthcare Sector – Pharmaceutical Packaging
$微創醫療(00853.HK)$$威高股份(01066.HK)$$石藥集團(01093.HK)$$國藥控股(01099.HK)$$華潤醫療(01515.HK)$$康臣葯業(01681.HK)$$春立醫療(01858.HK)$$環球醫療(02666.HK)$$復宏漢霖(02696.HK)$$創業慧康(300451.SZ)$$柳藥集團(603368.SH)$$百濟神州(06160.HK)$
DBS: China Biotech Sector
$百濟神州(06160.HK)$$石藥集團(01093.HK)$$復宏漢霖(02696.HK)$$微創醫療(00853.HK)$$威高股份(01066.HK)$$國藥控股(01099.HK)$$華潤醫療(01515.HK)$$康臣葯業(01681.HK)$$春立醫療(01858.HK)$$環球醫療(02666.HK)$$復宏漢霖(02696.HK)$$創業慧康(300451.SZ)$$柳藥集團(603368.SH)$$百濟神州(06160.HK)$
DBS: China Resources Medical Holdings Co Ltd – BUY TO HK$9.40
$華潤醫療(01515.HK)$
暫無評論